Abstract

ObjectivesSelection criteria for palliative limited surgery in patients with non-small cell lung cancer (NSCLC) can vary by institution or surgeon. We retrospectively reviewed outcomes of poor-risk patients who underwent palliative segmentectomy (PS), using the National Clinical Database Risk Calculator (RC).MethodsWe retrospectively analyzed medical records of patients with NSCLC tumors ≥ 20 mm and consolidation/tumor ratios ≥ 0.5 on computed tomography, who underwent PS from January 2009 to March 2016. Median follow-up time was 47 months (range 2–102 months).ResultsWe enrolled 67 patients (median age: 73.0 years), of whom 54 received thoracoscopic surgery and 28 received medial lymph-node dissection. The RC’s mean predictive probability rate for perioperative mortality or severe complications was 7.1%. Of the 67 patients, 24 patients (43.0%) suffered post-surgical complications, including 2 (3%) who died in hospital; 17 eventually suffered NSCLC recurrences and/or metastases, 11 eventually died from NSCLC, and 17 died from other diseases. Five-year overall survival (OS) was 59.4%. When the patients were divided into high-risk (HR) and low-risk (LR) groups based on the RC, 5-year OS was significantly less in the HR group (43.9%) than in the LR group (82.2%; P < 0.05).ConclusionThe RC, which was developed primarily to determine perioperative risk, can predict long-term prognosis for compromised patients who undergo PS.

Highlights

  • Lobectomy is a recommended standard surgical procedure for non-small cell lung cancer (NSCLC), based on results of a randomized-controlled trial by the Lung Cancer Study Group (LCSG) that compared sublobar resection (SLR) with lobectomy [1]

  • SLR’s safety and prognostic effect on long-term survival compared with lobectomy, and patient subgroups that can potentially benefit from SLR are unclear [3]

  • It is linked to the second level in the specialty chest surgery hierarchy through a web-based conversion, both of which are supported by the Japanese Board of General Thoracic Surgery [5]

Read more

Summary

Introduction

Lobectomy is a recommended standard surgical procedure for non-small cell lung cancer (NSCLC), based on results of a randomized-controlled trial by the Lung Cancer Study Group (LCSG) that compared sublobar resection (SLR) with lobectomy [1]. SLR has been conventionally used as a compromise procedure for poor-risk patients with lung cancer when lobectomy is not considered feasible [2]. Selection criteria for limited palliative surgery for NSCLC are not standardized, and can differ among institutions and surgeons. SLR’s safety and prognostic effect on long-term survival compared with lobectomy, and patient subgroups that can potentially benefit from SLR are unclear [3]. Our institutional preference is to perform pulmonary segmentectomy for wider surgical margins and more detailed nodal assessments. General Thoracic and Cardiovascular Surgery (2021) 69:1096–1104

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call